In recent months, researchers have begun to explore the potential use of Ivermectin 12mg[https://buyivermectin24.com/product/buy-ivermectin-12-mg-online/] in treating COVID-19. A number of studies have been conducted on animals and humans, with promising results.

However, more research is needed to confirm its efficacy and safety in treating this virus. Moreover, there is still uncertainty about the optimal dose and duration of treatment. Additionally, there are questions about whether Ivermectin can be used to prevent infection in those who are exposed to the virus.

Furthermore, while some early studies suggest that Ivermectin 6[https://buyivermectin24.com/product/buy-iverjohn-6-mg-ivermectin/] could potentially reduce mortality associated with COVID-19, larger clinical trials will be necessary to prove any such effect. Additionally, there are concerns about possible side effects when using higher doses of the medication.

Currently, the FDA has not approved Ivermectin 12[https://buyivermectin24.com/product/buy-iverjohn-12-mg-ivermectin/] for use against COVID-19; however, several countries are already using it off-label due to the lack of other effective treatments. Going forward, further clinical trials are necessary to determine if Ivermectin can be safely and effectively utilized against COVID-19. Ultimately, these studies will be key in helping us understand if Ivermectin holds any promise in fighting this deadly virus https://buyivermectin24.com/.